Skip to main content
OpenTrials

Clinical trial condition

Mouth Neoplasms

Explore clinical trials studying Mouth Neoplasms. Study availability and eligibility vary by location and protocol.

246 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Mouth Neoplasms trial results

Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT06695845

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +64 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • Rocky Mountain Cancer Center Littleton, Colorado, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
View all 28 locations
View Trial Details
Recruiting

Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, An Unblinded: Randomized Pilot Study

NCT07124520

Conditions
Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Commack, New York, United States
View Trial Details
Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

NCT05408845

Conditions
Head and Neck Neoplasms, Metastatic Salivary Gland Carcinoma, Mouth Diseases, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
View all 152 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

NCT04969835

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +33 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
  • The Beatson West of Scotland Cancer Centre, NHS Greater Glasgow & Clyde Glasgow, United Kingdom
View Trial Details
Recruiting

Oropharynx (OPX) Biomarker Trial

NCT06356272

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +29 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions